Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-29

FDA Approved: EZETIMIBE — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

The FDA approved a supplemental application for ezetimibe filed by Quallent Pharmaceuticals Health LLC. This confirms approval of a new or modified generic prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

SUPPL AP for EZETIMIBE (EZETIMIBE)